Open
🩺 Health
General
#42142
🎯 One of 14 candidates in the same event.
This market trades and resolves entirely on its own -- buying Yes here pays out only if
this specific outcome happens, regardless of what happens to the others. Prices across
the 14 candidates are not required to add up to 100% --
each one is priced independently, the same way Kalshi/Polymarket's own multi-candidate events work.
See all 14 candidates »
Will there be at least 6500 measles cases in the U.S. in 2026?
71.00Ᵽ
seed price — no trades yet
Call Yes
49.00Ᵽ – 53.00Ᵽ
Call No
47.00Ᵽ – 51.00Ᵽ
📡 Polymarket: 51%
Two different numbers on purpose: Polymarket's is the outside reference, Profet's is what actually moves credits here.
49.00Ᵽ best bid · 53.00Ᵽ best ask
🔵 On Polymarket (at import): $48,613 volume
Price history
This platform
Polymarket (indicative)
Loading…
Polymarket's price is shown for reference only -- this platform's own order book sets its own price, and the two can diverge.
Log in to trade this market.
Order book
Loading…
How much do you disagree with this price?
Pick 1 (barely) to 5 (strongly) -- a pure sentiment vote, not a trade, not tied to credits.
Log in to add your own rating.
No one's rated this yet -- be the first.
Resolution
- Source
- Polymarket (via UMA optimistic oracle) ✓ Verified source
- Event cutoff
- Rules
- This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Comments
Log in to join the discussion.
No comments yet -- be the first to say something.